^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BT1718
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Bicycle Therap
Drug class:
Microtubule inhibitor, MMP-14 inhibitor
Related drugs:
Phase 1/2
Cancer Research UK
Completed
Last update posted :
02/07/2024
Initiation :
01/24/2018
Primary completion :
11/20/2023
Completion :
11/20/2023
MMP14
|
BT1718
Share
